CVRx, Inc. (CVRX)
Nasdaq: CVRX · Surgical & Medical Instruments & Apparatus · Minneapolis, MN · filing with the SEC since 2003
Who runs CVRx, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Hykes Kevin
PRES & CEO. First filing Dec 2022, latest Mar 3, 2026, 3 filings in all.
Officers reporting now
8
of 15 people with a filing in the last fifteen months
Directors reporting now
7
23 people on the record since 2021
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Landry John | Chief Financial Officer | Nov 2026 | Nov 12, 2026 | none |
| Binkowski Brent | CHIEF OPERATING OFFICER | Aug 2025 | Aug 13, 2026 | 1 · $0.00 |
| Adamson Philip B. | Chief Medical Officer | Feb 2025 | Mar 16, 2026 | 1 · $0.00 |
| Morrison Gregory | CHIEF HUMAN RESOURCES OFFICER | Mar 2026 | Mar 4, 2026 | none |
| Hykes Kevin | PRES & CEO | Dec 2022 | Mar 3, 2026 | 1 · $100,000 |
| Oasheim Jared | CHIEF FINANCIAL OFFICER | Jun 2021 | Mar 3, 2026 | 1 · $0.00 |
| John Robert Allen | Chief Revenue Officer | Jul 2024 | Mar 3, 2026 | 1 · $0.00 |
| Verrastro Paul | CHIEF MKTG & STRAT OFFICER | Jun 2021 | Mar 3, 2026 | 1 · $0.00 |
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Ballinger Kevin J. | director | Sep 2024 | Jun 3, 2026 | none |
| Dale Michael D | director | Jun 2026 | Jun 3, 2026 | none |
| Hill, Mitch C. | director | Sep 2024 | Jun 3, 2026 | none |
| Jain Mudit K. | director | Jun 2021 | Jun 3, 2026 | none |
| Nielsen Kirk G. | director | Jun 2021 | Jun 3, 2026 | none |
| Shadan Martha | director | Jul 2021 | Jun 3, 2026 | none |
| Slattery Joseph P | director | Jun 2021 | Jun 3, 2026 | none |
Owners of more than 10% of a classsales are open-market, Nov 12, 2025 to Nov 12, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Johnson & Johnson | 10% owner | Jun 2021 | Jan 8, 2026 | 4 · $100,000 |
| Johnson & Johnson Innovation - Jjdc, Inc. | 10% owner | Jun 2021 | Jan 8, 2026 | 2 · $200,000 |
Earlier names on the record12, newest filing first
Behbahani Ali · director · last filing Jun 2024Palmer Craig E. · officer · last filing Mar 2024Yared Nadim · officer · last filing Feb 2024Galle Liz · officer · last filing Oct 2023Bruhn-Ding Dean · officer · last filing Aug 2022Nehra John M · director · last filing Jun 2022Brintnall John · officer · last filing Apr 2022Nea Partners 10 L P · 10% owner · last filing Jul 2021New Enterprise Associates 10 L P · 10% owner · last filing Jul 2021Sandell Scott D · 10% owner · last filing Jul 2021Glaxosmithkline PLC · 10% owner · last filing Jul 2021Pardo Geoffrey B · director · last filing Jul 2021
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.